לוקובורין טבע 10 מגמל ישראל - עברית - Ministry of Health

לוקובורין טבע 10 מגמל

abic marketing ltd, israel - calcium folinate - תמיסה להזרקה - calcium folinate 10.8 mg/ml - calcium folinate - calcium folinate - to diminish the toxicity and counteract the action of folic acid antagonists in cytotoxic therapy. as leucovorin-fluorouracil chemotherapy combination for cancer treatment.

קלציומפולינט אבווה 10 מגמל ישראל - עברית - Ministry of Health

קלציומפולינט אבווה 10 מגמל

novartis israel ltd - calcium folinate - תמיסה להזרקה - calcium folinate 10 mg/ml - calcium folinate - calcium folinate - to diminish the toxicity and counteract the action of the folic antagonists in cytotoxic therapy. as leukovorin-fluorouracil chemotherapy combination for cancer treatment.

קובאלטרי IU 1000 ישראל - עברית - Ministry of Health

קובאלטרי iu 1000

bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 1000 iu - coagulation factor viii

קובאלטרי IU 2000 ישראל - עברית - Ministry of Health

קובאלטרי iu 2000

bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 2000 iu - coagulation factor viii

קובאלטרי IU 250 ישראל - עברית - Ministry of Health

קובאלטרי iu 250

bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 250 iu - coagulation factor viii

קובאלטרי IU 500 ישראל - עברית - Ministry of Health

קובאלטרי iu 500

bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 500 iu - coagulation factor viii

פולמוזיים ישראל - עברית - Ministry of Health

פולמוזיים

roche pharmaceuticals (israel) ltd - recombinant human deoxyribonuclease - תמיסה לשאיפה - recombinant human deoxyribonuclease 1 mg/ml - dornase alfa (desoxyribonuclease) - dornase alfa (desoxyribonuclease) - management of cystic fibrosis not for patients under 5 years of age or with fvc<40% .

לוקובורין טבע טבליות ישראל - עברית - Ministry of Health

לוקובורין טבע טבליות

teva israel ltd - calcium folinate - טבליה - calcium folinate 16.2 mg - detoxifying agents for antineoplastic treatment - counteracts the action of folic acid antagonists. improves blood picture in megaloblastic anemias due to folate deficiency. as leucovorin- fluorouracil combination chemotherapy in cancer.

אפרקס 1000 ישראל - עברית - Ministry of Health

אפרקס 1000

j-c health care ltd - recombinant human erythropoietin - תמיסה להזרקה - recombinant human erythropoietin 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat

אפרקס 2000 ישראל - עברית - Ministry of Health

אפרקס 2000

j-c health care ltd - recombinant human erythropoietin - תמיסה להזרקה - recombinant human erythropoietin 2000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat